Standards of care for type 2 diabetes in China-Reference-Cited by-同舟云学术

Standards of care for type 2 diabetes in China

Published:2016-07 Issue:5 Volume:32 Page:442-458
ISSN:1520-7552
Container-title:Diabetes/Metabolism Research and Reviews
language:en
Short-container-title:Diabetes Metab Res Rev

Author:

Weng Jianping¹,Ji Linong²,Jia Weiping³,Lu Juming⁴,Zhou Zhiguang⁵,Zou Dajin⁶,Zhu Dalong⁷,Chen Liming⁸,Chen Li⁹,Guo Lixin¹⁰,Guo Xiaohui¹¹,Ji Qiuhe¹²,Li Qifu¹³,Li Xiaoying¹⁴,Liu Jing¹⁵,Ran Xingwu¹⁶,Shan Zhongyan¹⁷,Shi Lixin¹⁸,Song Guangyao¹⁹,Yang Liyong²⁰,Yang Yuzhi²¹,Yang Wenying²²,

Affiliation:

1. Department of Endocrinology and Metabolism, Guangdong Provincial Key Laboratory of Diabetology; The Third Affiliated Hospital of Sun Yat-Sen University; Guangzhou China

2. Department of Endocrinology; Peking University People's Hospital; Beijing China

3. Shanghai Diabetes Institute, Shanghai Clinical Center for Diabetes, Shanghai Key Laboratory of Diabetes Mellitus; Shanghai Jiao Tong University Affiliated Sixth People's Hospital; Shanghai China

4. Department of Endocrinology; Chinese People's Liberation Army General Hospital; Beijing China

5. Institute of Metabolism and Endocrinology, Key Laboratory of Diabetes Immunology, Ministry of Education, National Clinical Research Center for Metabolic Diseases, The Second Xiangya Hospital and the Diabetes Center; Central South University; Changsha China

6. Department of Endocrinology, Changhai Hospital; Second Military Medical University; Shanghai China

7. Department of Endocrinology, Nanjing Drum Tower Hospital; The Affiliated Hospital of Nanjing University Medical School; Nanjing China

8. Tianjin Metabolic Diseases Hospital & Tianjin Institute of Endocrinology; Tianjin Medical University; Tianjin China

9. Department of Endocrinology; Qilu Hospital of Shandong University; Ji'nan China

10. Department of Endocrinology; Beijing Hospital; Beijing China

11. Department of Endocrinology; Peking University First Hospital; Beijing China

12. Department of Endocrinology, Xijing Hospital; Fourth Military Medical University; Xi'an China

13. Department of Endocrinology; The First Affiliated Hospital of Chongqing Medical University; Chongqing China

14. Department of Endocrinology, Rui Jin Hospital; Shanghai Jiao Tong University School of Medicine; Shanghai China

15. Department of Endocrinology; Gansu Provincial Hospital; Lanzhou China

16. Department of Endocrinology and Metabolism, West China Hospital; Sichuan University; Chengdu China

17. Department of Endocrinology; The First Hospital of China Medical University; Shenyang China

18. Department of Endocrinology; Affiliated Hospital of Guiyang Medical University; Guiyang China

19. Department of Endocrinology; Hebei General Hospital; Shijiazhuang China

20. Department of Endocrinology; The First Affiliated Hospital of Fujian Medical University; Fuzhou China

21. Department of Endocrinology; Heilongjiang Provincial Hospital; Harbin China

22. Department of Endocrinology; China Japan Friendship Hospital; Beijing China

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/dmrr.2827/fullpdf

Reference97 articles.

1. A mass survey of diabetes mellitus in a population of 300,000 in 14 provinces and municipalities in China;National Diabetes Study Group;Zhonghua Nei Ke Za Zhi,1981

2. National Diabetes Prevention and Control Cooperative Group;Pan;Diabetes Care,1997

3. A description on the Chinese national nutrition and health survey in 2002;Li;Zhonghua Liu Xing Bing Xue Za Zhi,2005

4. Prevalence of diabetes among men and women in China;Yang;N Engl J Med,2010

5. China guideline for type 2 diabetes (2010);Chinese Diabetes Society;Chin J Diabetes,2012

Cited by 252 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diabetes mellitus and Alzheimer's disease: Understanding disease mechanisms, their correlation, and promising dual activity of selected herbs;Journal of Ethnopharmacology;2024-10

2. SGLT‐2 inhibitors and high‐dose acarbose as potential high‐risk combinations for ketosis and ketoacidosis in Asian patients with T2DM: A case series;Clinical Case Reports;2024-09

3. The predictive value of the triglyceride glucose index combined with cystatin C for the prognosis of patients with acute coronary syndrome;Frontiers in Endocrinology;2024-08-14

4. Specific metabolic impairments indicate loss of sustained liver improvements in metabolic dysfunction-associated steatotic liver disease treatment;Hepatobiliary Surgery and Nutrition;2024-08

5. Current type 2 diabetes guidelines: Individualized treatment and how to make the most of metformin;Diabetes, Obesity and Metabolism;2024-07-11